These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1736010)

  • 1. Transformation of murine pre-B-lymphocytes by v-erb-B: progression to growth factor independence and tumorigenicity.
    Miller M; Kennewell A; Symonds G
    Leukemia; 1992 Jan; 6(1):18-28. PubMed ID: 1736010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation of early erythroid precursor cells (BFU-E) by a recombinant murine retrovirus containing v-erb-B.
    Miller M; Kennewell A; Takayama Y; Bruskin A; Bishop JM; Johnson G; Symonds G
    Oncogene; 1990 Aug; 5(8):1125-31. PubMed ID: 2168027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation of FDC-P1 cells to IL-3 independence by a recombinant murine retrovirus containing v-erb-B.
    Shounan Y; Miller M; Symonds G
    Exp Hematol; 1995 Jun; 23(6):492-9. PubMed ID: 7768304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
    Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
    J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor progression following transformation of murine monocytes by v-myc: acquisition of immortalization and tumorigenicity.
    Stapleton P; Takayama Y; Hartshorn A; Kalaizis A; Rowe PB; Symonds G
    Oncogene; 1991 May; 6(5):807-17. PubMed ID: 1711191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of pre-B lymphoid leukemia following reconstitution of lethally irradiated mice with v-erb-B virus-infected bone marrow progenitor cells.
    Miller M; Symonds G
    Cell Growth Differ; 1993 Feb; 4(2):125-35. PubMed ID: 8494783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy of IL-7 and v-Ha-ras in the in vitro neoplastic progression of murine pre-B cells.
    Chen SC; Redenius D; Young JC; Schwartz RC
    Oncogene; 1993 Aug; 8(8):2119-25. PubMed ID: 8336938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multistage progression of Abelson virus-infected murine pre-B-cells to the tumorigenic state.
    Palumbo GJ; Ozanne BW; Kettman JR
    Cancer Res; 1990 Mar; 50(6):1917-23. PubMed ID: 2155061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique lymphoid cell subset target to infection and proliferation induced in vitro by a murine leukemia virus.
    O'Neill HC
    Leukemia; 1992 Apr; 6(4):272-81. PubMed ID: 1588790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro.
    Cleveland JL; Jansen HW; Bister K; Fredrickson TN; Morse HC; Ihle JN; Rapp UR
    J Cell Biochem; 1986; 30(3):195-218. PubMed ID: 3084503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six amino acids from the retroviral gene gag greatly enhance the transforming potential of the oncogene v-erb-B.
    Bruskin A; Jackson J; Bishop JM; McCarley DJ; Schatzman RC
    Oncogene; 1990 Jan; 5(1):15-24. PubMed ID: 1969616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of growth factor-independence and GM-CSF secretion by the v-src oncogene in murine myeloid cells does not require membrane association of pp60v-src.
    Ostermeyer AG; Anderson SM
    Exp Hematol; 1996 Feb; 24(2):176-84. PubMed ID: 8641339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation of murine myelomonocytic cells by myc: point mutations in v-myc contribute synergistically to transforming potential.
    Symonds G; Hartshorn A; Kennewell A; O'Mara MA; Bruskin A; Bishop JM
    Oncogene; 1989 Mar; 4(3):285-94. PubMed ID: 2649846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine production of pre-B-cell stimulating activity by a variety of transformed murine pre-B-cell lines.
    Lemoine FM; Krystal G; Humphries RK; Eaves CJ
    Cancer Res; 1988 Nov; 48(22):6438-43. PubMed ID: 3263188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation.
    Dolnikov A; Millington M; Sun LQ; Symonds G
    Cancer Gene Ther; 2000 Nov; 7(11):1491-503. PubMed ID: 11129291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of multiple hemopoietic growth factor genes in Abelson virus-transformed myeloid cells.
    Humphries RK; Abraham S; Krystal G; Lansdorp P; Lemoine F; Eaves CJ
    Exp Hematol; 1988 Oct; 16(9):774-81. PubMed ID: 2844575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of macrophage cell line from fresh bone marrow cells with a myc/raf recombinant retrovirus.
    Blasi E; Radzioch D; Merletti L; Varesio L
    Cancer Biochem Biophys; 1989 Oct; 10(4):303-17. PubMed ID: 2695237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The v-erb A oncogene causes repression of erythrocyte-specific genes and an immature, aberrant differentiation phenotype in normal erythroid progenitors.
    Schroeder C; Raynoschek C; Fuhrmann U; Damm K; Vennström B; Beug H
    Oncogene; 1990 Oct; 5(10):1445-53. PubMed ID: 1979159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multinucleation in the presence of cytochalasin B by RNA tumor virus-transformed cells.
    Somers KD; Murphey MM
    Cancer Res; 1980 Dec; 40(12):4410-4. PubMed ID: 6254645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroviral infection can abrogate the factor-dependency of hematopoietic cells by autocrine and non-autocrine mechanisms depending on the presence of a functional viral oncogene.
    McCubrey JA; Smith SR; Algate PA; DeVente JE; White MK; Steelman LS
    Oncogene; 1993 Nov; 8(11):2905-15. PubMed ID: 8414494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.